Digital Twins

New roadmap explores how causal inference and digital twins could transform clinical trials

by ccaim-comms@damtp.cam.ac.uk
21 July 2026

A new Perspective published in npj Digital Medicine from CCAIM brings together academic and industry partners, led by Professor Mihaela van der Schaar, to explore how causal inference and digital twins could support more adaptive, efficient and patient-centred clinical trials.

CCAIM researchers publish manifesto on AI-driven transformation of clinical trials

by ccaim-comms@damtp.cam.ac.uk
02 October 202506 October 2025

The CCAIM has published a landmark manifesto outlining how AI technologies – causal inference and digital twins – can transform clinical trials. This collaborative publication, co-authored with all CCAIM strategic partners – AstraZeneca, GSK, Sanofi, Boehringer Ingelheim, and QuantumBlack – charts a roadmap for faster, safer, and more inclusive medical research.